🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 12 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/07/1994 | 43,04 | 43,04 | 43,04 | 43,04 | -4,17% | 0,00% | 401 |
| 14/07/1994 | 45,85 | 45,85 | 43,04 | 44,92 | +4,35% | 6,12% | 641 |
| 13/07/1994 | 43,04 | 45,85 | 43,04 | 43,04 | -8,00% | 6,52% | 3.286 |
| 12/07/1994 | 46,79 | 46,79 | 46,79 | 46,79 | +0,00% | 0,00% | 0 |
| 11/07/1994 | 46,79 | 46,79 | 43,98 | 46,79 | +0,00% | 6,00% | 401 |
| 08/07/1994 | 44,45 | 46,79 | 43,98 | 46,79 | +0,00% | 6,32% | 12.610 |
| 07/07/1994 | 43,04 | 49,59 | 43,04 | 46,79 | +8,70% | 15,22% | 8.710 |
| 06/07/1994 | 43,04 | 43,04 | 43,04 | 43,04 | +0,00% | 0,00% | 1.656 |
| 05/07/1994 | 46,79 | 46,79 | 43,04 | 43,04 | -6,12% | 8,00% | 53 |
| 01/07/1994 | 43,04 | 45,85 | 43,04 | 45,85 | +0,00% | 6,52% | 1.416 |
| 30/06/1994 | 42,11 | 45,85 | 40,24 | 45,85 | +15,29% | 13,33% | 9.965 |
| 29/06/1994 | 41,17 | 41,17 | 38,37 | 39,77 | +3,66% | 6,82% | 721 |
| 28/06/1994 | 43,04 | 43,98 | 38,37 | 38,37 | -10,87% | 13,04% | 10.580 |
| 27/06/1994 | 45,85 | 45,85 | 43,04 | 43,04 | -6,12% | 6,12% | 588 |
| 24/06/1994 | 43,98 | 45,85 | 43,04 | 45,85 | +6,52% | 6,38% | 1.149 |
| 23/06/1994 | 43,98 | 43,98 | 43,04 | 43,04 | -2,13% | 2,13% | 107 |
| 22/06/1994 | 45,85 | 45,85 | 43,04 | 43,98 | +0,00% | 6,12% | 588 |
| 21/06/1994 | 44,92 | 44,92 | 43,98 | 43,98 | -2,08% | 2,08% | 2.405 |
| 20/06/1994 | 47,72 | 47,72 | 44,92 | 44,92 | -5,88% | 5,88% | 668 |
| 17/06/1994 | 47,72 | 47,72 | 45,85 | 47,72 | +3,03% | 3,92% | 5.557 |
| 16/06/1994 | 45,85 | 46,32 | 45,85 | 46,32 | +1,02% | 1,02% | 374 |
| 15/06/1994 | 46,79 | 46,79 | 45,85 | 45,85 | -3,92% | 2,00% | 481 |
| 14/06/1994 | 44,92 | 47,72 | 44,92 | 47,72 | +4,08% | 6,25% | 6.011 |
| 13/06/1994 | 45,85 | 46,79 | 44,92 | 45,85 | +0,00% | 4,08% | 1.523 |
| 10/06/1994 | 43,04 | 45,85 | 43,04 | 45,85 | +2,08% | 6,52% | 107 |
| 09/06/1994 | 44,92 | 44,92 | 44,92 | 44,92 | +0,00% | 0,00% | 935 |
| 08/06/1994 | 44,92 | 44,92 | 44,92 | 44,92 | +4,35% | 0,00% | 27 |
| 07/06/1994 | 44,92 | 44,92 | 43,04 | 43,04 | -4,17% | 4,17% | 775 |
| 06/06/1994 | 43,04 | 44,92 | 43,04 | 44,92 | +4,35% | 4,35% | 1.176 |
| 03/06/1994 | 43,04 | 43,04 | 43,04 | 43,04 | -6,12% | 0,00% | 294 |